Share-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Share-based Payment Arrangement [Abstract] |
|
| Schedule of Share-based Payment Award, Valuation Assumptions |
The following table includes the weighted-average assumptions used in estimating the fair values and the resulting weighted-average fair value of stock options granted in the periods presented: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2021 | | 2020 | | 2019 | | Weighted average fair values of stock options granted | $ | 15.53 | | | $ | 15.58 | | | $ | 12.68 | | | Expected volatility | 77.1 | % | | 64.7 | % | | 36.0 | % | | Expected dividends | .99 | % | | .84 | % | | .65 | % | | Weighted average risk-free interest rate | .93 | % | | .24 | % | | 1.72 | % | | Expected life of stock options (in years) | 3.5 | | 3.5 | | 3.5 |
|
| Schedule of Stock Options Activity |
A summary of stock option activity for the years ended December 31, 2021, 2020, and 2019 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Shares | | Weighted
Average
Exercise Price | | Weighted
Average
Remaining
Contractual
Term (Years) | | Aggregate Intrinsic
Value | | | | | | | | | (In thousands) | | Outstanding at January 1, 2019 | 162,000 | | | $ | 42.75 | | | 3.05 | | $ | — | | | Granted | 66,000 | | | $ | 46.75 | | | | | | | Exercised | — | | | $ | — | | | | | | | Canceled | (10,125) | | | $ | 46.66 | | | | | | | Outstanding at December 31, 2019 | 217,875 | | | $ | 43.78 | | | 2.60 | | $ | — | | | Granted | 36,000 | | | $ | 35.70 | | | | | | | Exercised | (30,000) | | | $ | 21.19 | | | | | | | Canceled | (6,000) | | | $ | 28.59 | | | | | | | Outstanding at December 31, 2020 | 217,875 | | | $ | 45.97 | | | 2.57 | | $ | — | | | Granted | 42,000 | | | $ | 30.40 | | | | | | | Exercised | — | | | $ | — | | | | | | | Canceled | (40,875) | | | $ | 49.22 | | | | | | | Outstanding at December 31, 2021 | 219,000 | | | $ | 42.38 | | | 2.80 | | $ | — | | | Exercisable at December 31, 2021 | 114,000 | | | $ | 47.43 | | | 1.84 | | $ | — | |
|
| Schedule of Nonvested Share Activity |
A summary of non-vested options and changes for the years ended December 31, 2021, 2020 and 2019 is as follows: | | | | | | | | | | | | | Non-Vested Number of Shares | | Weighted
Average
Exercise Price | | | | | | | Non-vested balance at January 1, 2019 | 81,750 | | | $ | 47.21 | | | Granted | 66,000 | | | $ | 46.75 | | | Vested | (28,875) | | | $ | 48.46 | | | Canceled | (10,125) | | | $ | 46.66 | | | Non-vested balance at December 31, 2019 | 108,750 | | | $ | 46.65 | | | Granted | 36,000 | | | $ | 35.70 | | | Vested | (42,000) | | | $ | 47.66 | | | Canceled | — | | | $ | — | | | Non-vested balance at December 31, 2020 | 102,750 | | | $ | 42.40 | | | Granted | 42,000 | | | $ | 30.40 | | | Vested | (39,750) | | | $ | 44.24 | | | Canceled | — | | | $ | — | | | Non-vested balance at December 31, 2021 | 105,000 | | | $ | 36.90 | |
|
| Schedule of Shares Authorized under Stock Option Plans, by Exercise Price Range |
The following table summarizes information about stock options outstanding by price range as of December 31, 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Options Exercisable | | Exercise Prices | | Number Outstanding | | Weighted-Average Remaining Contractual Life (Years) | | Weighted-Average Exercise Price | | Number of Shares | | Weighted-Average Exercise Price | | $30.40 | | 42,000 | | | 0.94 | | $ | 5.83 | | | — | | | $ | — | | | $35.70 | | 36,000 | | | 0.65 | | $ | 5.87 | | | 9,000 | | | $ | 2.82 | | | $41.60 | | 36,000 | | | 0.45 | | $ | 6.84 | | | 20,250 | | | $ | 7.39 | | | $42.56 | | 36,000 | | | 0.33 | | $ | 6.99 | | | 27,000 | | | $ | 10.08 | | | $52.92 | | 30,000 | | | 0.33 | | $ | 7.25 | | | 18,750 | | | $ | 8.70 | | | $53.90 | | 39,000 | | | 0.09 | | $ | 9.60 | | | 39,000 | | | $ | 18.44 | | | | 219,000 | | | 2.80 | | $ | 42.38 | | | 114,000 | | | $ | 47.43 | |
|
| Schedule of Nonvested Restricted Stock Activity |
A summary of the status of the Company’s non-vested restricted stock grant shares is presented in the following table: | | | | | | | | | | | | | Shares | | Weighted-Average Grant Date
Fair Value | | Non-vested at January 1, 2019 | 40,416 | | | $ | 58.60 | | | Granted | 91,658 | | | $ | 50.54 | | | Vested | (24,120) | | | $ | 57.14 | | | Forfeited | — | | | $ | — | | | Non-vested at December 31, 2019 | 107,954 | | | $ | 52.08 | | | Granted | 388,089 | | | $ | 24.37 | | | Vested | (68,504) | | | $ | 52.49 | | | Forfeited | — | | | $ | — | | | Non-vested at December 31, 2020 | 427,539 | | | $ | 26.86 | | | Granted | 8,979 | | | $ | 27.84 | | | Vested | (213,993) | | | $ | 29.08 | | | Forfeited | — | | | $ | — | | | Non-vested at December 31, 2021 | 222,525 | | | $ | 24.76 | |
|